Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies

被引：0

作者：

Unger, Joseph M. ^{[1
]}

Hershman, Dawn L. ^{[2
]}

Osarogiagbon, Raymond U. ^{[3
]}

Gothwal, Anirudh ^{[4
]}

Anand, Seerat ^{[5
]}

Dasari, Arvind ^{[5
]}

Overnman, Michael ^{[5
]}

Loree, Jonathan M. ^{[6
]}

Raghav, Kanwal ^{[5
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[2] Columbia Univ, New York, NY USA

[3] Baptist Canc Ctr, Memphis, TN USA

[4] Baylor Univ, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[6] BC Canc, Vancouver, BC, Canada

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-4344

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4344

引用

页数：2

共 50 条

[41] SYMPOSIUM NUTRITION IN CAUSATION OF CANCER SPONSORED BY AMERICAN CANCER SOCIETY AND NATIONAL CANCER INSTITUTE - FOREWORD
MILDER, JW
CANCER RESEARCH, 1975, 35 (11) : 3237 - 3237
[42] Analysis of esophagogastric cancer patients enrolled in National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP)-sponsored phase I trials
Bando, Hideaki
Rubinstein, Larry
Harris, Pamela Jo
Yoshino, Takayuki
Doi, Toshihiko
Ohtsu, Atsushi
Welch, Jack
Takebe, Naoko
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
[43] Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment
Philip, Philip A.
Mooney, Margaret
Jaffe, Deborah
Eckhardt, Gail
Moore, Malcolm
Meropol, Neal
Emens, Leisha
O'Reilly, Eileen
Korc, Murray
Ellis, Lee
Benedetti, Jacqueline
Rothenberg, Mace
Willett, Christopher
Tempero, Margaret
Lowy, Andrew
Abbruzzese, James
Simeone, Diane
Hingorani, Sunil
Berlin, Jordan
Tepper, Joel
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) : 5660 - 5669
[44] Early closure of clinical trials: The experience of the National Cancer Institute of Canada Clinical Trials Group.
Parulekar, W.
Pater, J. L.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 314S - 314S
[45] Lack of publication bias in randomized clinical trials (RCTs) sponsored by the National Cancer Institute MCI) and performed by Cooperative Oncology Groups (COGs).
Soares, HP
Kumar, A
Daniels, S
Sargent, DJ
Buckner, JC
Swann, S
Smith, RE
Khyatat, A
Wells, RJ
Djulbegovic, B
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 520S - 520S
[46] Agencies join forces to boost the number of veterans in cancer clinical trials A new program is helping to make National Cancer Institute-sponsored trials more accessible to a vulnerable population
Printz, Carrie
CANCER, 2019, 125 (12) : 1955 - 1956
[47] Analysis of Maryland Cancer Patient Participation in National Cancer Institute-Supported Cancer Treatment Clinical Trials
Baquet, Claudia R.
Ellison, Gary L.
Mishra, Shiraz I.
JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2009, 20 (02) : 120 - 134
[48] Analysis of Maryland cancer patient participation in National Cancer Institute-supported cancer treatment clinical trials
Baquet, Claudia R.
Ellison, Gary L.
Mishra, Shiraz I.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) : 3380 - 3386
[49] Current Academic Clinical Trials in Ovarian Cancer Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009
Trimble, Edward L.
Birrer, Michael J.
Hoskins, William J.
Marth, Christian
Petryshyn, Ray
Quinn, Michael
Thomas, Gillian M.
Kitchener, Henry C.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (07) : 1284 - 1298
[50] Trends in disparities in clinical trial accrual: An analysis of National Cancer Institute (NCI)-sponsored early phase clinical trials over the last 22 years
Farooq, Maria
Sharon, Elad
Takebe, Naoko
Best, Ana F.
Finnigan, Shanda
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)

← 1 2 3 4 5 →